A comparative study of first-derivative spectrophotometry and high-performance liquid chromatography applied to the determination of losartan potassium in tablets

Chemical and Pharmaceutical Bulletin

Volumn 52, Issue 10, 2004, Pages 1166-1170

  Ansari, Mehdi ^a   Kazemipour, Maryam ^b   Khosravi, Freshteh ^b   Baradaran, Mehdi ^a  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

First derivative spectrophotometry; HPLC; Losartan; Tablet

Indexed keywords

EXCIPIENT; LOSARTAN POTASSIUM; LOSARTAN;

ANALYTIC METHOD; ARTICLE; CONCENTRATION (PARAMETERS); DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG SCREENING; ECONOMIC ASPECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERMETHOD COMPARISON; LABORATORY; MEASUREMENT; METHODOLOGY; QUALITY CONTROL; RADIATION ABSORPTION; RECORDING; SENSITIVITY ANALYSIS; SPECTROPHOTOMETER; SPECTROPHOTOMETRY; TABLET; ULTRAVIOLET SPECTROSCOPY; CHEMISTRY; COMPARATIVE STUDY; COST; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; ULTRAVIOLET SPECTROPHOTOMETRY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COSTS AND COST ANALYSIS; LOSARTAN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET; TABLETS;

EID: 16644375110     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.52.1166     Document Type: Article

References (18)

1. Toral M. I., Pope S., Quintanilla S., Richter P., Int. J. Pharm., 249, 117-126 (2002).
2. Wang L., Asgharnejad M., J. Pharm. Biomed. Anal., 21, 1243-1248 (2000).
3. Kazemipour M., Noroozian E., Tehrani M. S., Mahmoudian M., J. Pharm. Biomed. Anal., 30, 1379-1384 (2002).
4. Hassan E. M., J. Pharm. Biomed. Anal., 21, 1183-1189 (2000).
5. El-Gindy A., J. Pharm. Biomed. Anal., 22, 215-234 (2000).
6. Surekha A., Jain N. K., Indian Drugs, 37, 351-353 (2000).
7. Raggi M. A., Casamenti G., Mandrioli R., Izzo G., Kenndler E., J. Pharm. Biomed. Anal., 23, 973-981 (2000).
8. Karpinska J., Mikoluc B., Piotrowska J., J. Pharm. Biomed. Anal., 17, 1345-1350 (1998).
9. Uslu B., Özkan S. A., Anal. Chim. Acta, 466, 175-185 (2002).
10. Sultan M., Il Farmaco, 57, 865-870 (2002).
11. Bebawy L. I., Moustafa A. A., Abo-Talib N. F., J. Pharm. Biomed. Anal., 27, 779-793 (2002).
12. Ferraro M. C. F., Castellano P. M. C., Kaufman T. S., J. Pharm. Biomed. Anal., 26, 443-451 (2001).
13. Polinko M., Riffel K., Song H., Lo M. W., J. Pharm. Biomed. Anal., 33, 73-84 (2003).
14. Hertzog D. L., McCafferty J. F., Fang X., Tyrrell R. J., Reed R. A., J. Pharm. Biomed. Anal., 30, 747-760 (2002).
15. Tatar S., Saglik S., J. Pharm. Biomed. Anal., 30, 371-375 (2002).
16. Shah S. A., Rathod I. S., Suhagia B. N., Savale S. S., Patel J. B., J. AOAC Int., 84, 1715-1723 (2001).
17. Hillaert S., Van den Bossche W., J. Pharm. Biomed. Anal., 31, 329-339 (2003).
18. Gagigal E., Gonzalez L., Alonso R. M., Jimenez R. M., Talanta, 54, 1121-1133 (2001).